Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 3
2015 1
2016 1
2018 3
2019 5
2020 12
2021 15
2022 10
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Results by year
Filters applied: . Clear all
Page 1
Phage therapy for respiratory infections.
Chang RYK, Wallin M, Lin Y, Leung SSY, Wang H, Morales S, Chan HK. Chang RYK, et al. Adv Drug Deliv Rev. 2018 Aug;133:76-86. doi: 10.1016/j.addr.2018.08.001. Epub 2018 Aug 7. Adv Drug Deliv Rev. 2018. PMID: 30096336 Free PMC article. Review.
Lipid nanoparticles for the inhalation of mRNA.
Chang RYK, Chan HK. Chang RYK, et al. Nat Biomed Eng. 2021 Sep;5(9):949-950. doi: 10.1038/s41551-021-00794-x. Nat Biomed Eng. 2021. PMID: 34616049 No abstract available.
Cough as an adverse effect on inhalation pharmaceutical products.
Chang RYK, Kwok PCL, Ghassabian S, Brannan JD, Koskela HO, Chan HK. Chang RYK, et al. Br J Pharmacol. 2020 Sep;177(18):4096-4112. doi: 10.1111/bph.15197. Epub 2020 Aug 7. Br J Pharmacol. 2020. PMID: 32668011 Free PMC article. Review.
Administration of dry powders during respiratory supports.
Ke WR, Chang RYK, Kwok PCL, Tang P, Chen L, Chen D, Chan HK. Ke WR, et al. Among authors: chang ryk. Ann Transl Med. 2021 Apr;9(7):596. doi: 10.21037/atm-20-3946. Ann Transl Med. 2021. PMID: 33987294 Free PMC article. Review.
Dry powder pharmaceutical biologics for inhalation therapy.
Chang RYK, Chow MYT, Khanal D, Chen D, Chan HK. Chang RYK, et al. Adv Drug Deliv Rev. 2021 May;172:64-79. doi: 10.1016/j.addr.2021.02.017. Epub 2021 Mar 8. Adv Drug Deliv Rev. 2021. PMID: 33705876 Review.
46 results